MCM
STDY

Moore Capital Management’s SteadyMed Ltd STDY Stock Holding History

Moore Capital Management’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-225,000
Closed -$1.01M – 376
2018
Q2 		$1.01M Hold
225,000
– – 0.02% 215
2018
Q1 		$731K Hold
225,000
– – 0.01% 205
2017
Q4 		$833K Hold
225,000
– – 0.02% 218
2017
Q3 		$765K Buy
225,000
+75,000
+50% +$399K 0.01% 197
2017
Q2 		$945K Buy
+150,000
New +$1.02M 0.03% 158

Other funds holding STDY

AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Moore Capital Management's STDY Position: Q3 2018 in Review

Moore Capital Management sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 225,000 shares — an estimated $1.01M sold.

Moore Capital Management first reported a position in STDY in Q2 2017 and held it in 5 quarters. The position peaked at $1.01M in Q2 2018. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

  • Moore Capital Management reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
  • Moore Capital Management sold 225,000 SteadyMed Ltd shares in Q3 2018, an estimated $1.01M.
  • Moore Capital Management first reported a position in SteadyMed Ltd in Q2 2017 and held it in 5 quarters.
  • Moore Capital Management's SteadyMed Ltd position peaked at $1.01M in Q2 2018.
  • 5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Moore Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.